Status: Recruiting
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
This is a First-In-Human trial investigating a novel expansion protocol of an ATIMP (CC-38), composed of autologous TIL.
Participants needed: 12
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CuraCell TX ABUpdated: Jun 22, 2026Locations: 1
Eligibility criteria
Patient (female or male) has signed informed consent according to ICH/GCP and na... [+23]
Congestive heart failure NYHA class III or IV, [+35]